Transcription Factor GATA-1 in Erythro-Megakaryocytic Development and Leukemia

转录因子 GATA-1 在红巨核细胞发育和白血病中的作用

基本信息

  • 批准号:
    7345627
  • 负责人:
  • 金额:
    $ 20.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Most leukemias are caused by somatic mutations that disrupt transcription factor function. One example is GATA-1, a nuclear protein required for erythroid and megakaryocytic maturation. Nearly all patients with Down's Syndrome-associated transient myeloproliferative disorder (TMD) or acute megakaryoblastic leukemia (AMKL) exhibit somatic GATA1 gene mutations that result in the exclusive production of an abnormal amino-truncated protein, termed GATA-1 short. We showed that in murine embryonic stem cells and embryos, loss of GATA-1 causes a previously unappreciated block at the bipotential megakaryocytic-erythroid progenitor (MEP) stage of hematopoiesis, where development also appears to be perturbed in AMKL. The leukemia-associated GATA-1 short protein fails to relieve this block and actually drives proliferation in a subset of arrested MEPs. Hence, we hypothesize that GATA-1 promotes normal MEP maturation and that derangements in this function contribute to Down's syndrome-associated TMD and AMKL. In particular, we believe that loss of specific GATA-1 functions activate an aberrant self-renewal program in MEPs, which contributes to development of the leukemic stem cell. Now, we will define the genetic program through which normal GATA-1 controls MEP development and investigate how this program becomes deranged by GATA-1 short in murine ES cells and in human fetal hematopoietic progenitors from both normal and trisomy 21 individuals.
描述(由申请人提供):大多数白血病是由破坏转录因子功能的体细胞突变引起的。一个例子是加塔-1,一种红细胞和巨核细胞成熟所需的核蛋白。几乎所有患有唐氏综合征相关的暂时性骨髓增生性疾病(TMD)或急性巨核细胞白血病(AMKL)的患者都表现出体细胞GATA 1基因突变,其导致异常氨基截短蛋白(称为加塔-1短)的专门产生。我们发现,在小鼠胚胎干细胞和胚胎中,加塔-1的缺失导致造血的双能巨核细胞-红系祖细胞(MEP)阶段的先前未被认识到的阻滞,其中AMKL的发育似乎也受到干扰。白血病相关的加塔-1短蛋白不能缓解这种阻滞,实际上驱动了一部分被阻滞的MEP的增殖。因此,我们假设加塔-1促进正常的MEP成熟,并且该功能的紊乱有助于唐氏综合征相关的TMD和AMKL。特别是,我们认为特定加塔-1功能的丧失激活MEP中异常的自我更新程序,这有助于白血病干细胞的发展。现在,我们将定义正常加塔-1控制MEP发育的遗传程序,并研究该程序如何在小鼠ES细胞和正常和21三体个体的人胎儿造血祖细胞中被加塔-1短序列扰乱。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mitchell J Weiss其他文献

Adenine Base Editing Improves Erythropoiesis in Diamond-Blackfan Anemia Syndrome Patient-Derived Induced Pluripotent Stem Cells
  • DOI:
    10.1182/blood-2024-209312
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Shruthi Suryaprakash;Lei Han;Garret Manquen;Varun Katta;Damian Krzyzanowski;Jayaram Prasad;Nikitha Nimmagada;Kalin Mayberry;Nana Liu;Yan Ju;Yu Yao;Kelsey Ray;Marcin Wlodarski;Shengdar Q Tsai;Jonathan S Yen;Mitchell J Weiss;Senthil Velan Bhoopalan
  • 通讯作者:
    Senthil Velan Bhoopalan
Testing Rapamycin As an Anti-Adhesion Therapy for Sickle Cell Disease
  • DOI:
    10.1182/blood-2024-212384
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Danitza Nebor;Mitchell J Weiss;Jonathan M. Flanagan
  • 通讯作者:
    Jonathan M. Flanagan
Hematopoietic Stem Cells Supporting Fetal Erythropoiesis Are Differentially Regulated By Small and Large Ribosomal Subunits
  • DOI:
    10.1182/blood-2024-210699
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Yuefeng Tang;Te Ling;Rashid Mehmood;Mushran Khan;Julien Papoin;James Palis;Laurie A. Steiner;Sébastien Durand;Leonard I. Zon;Senthil Velan Bhoopalan;Mitchell J Weiss;Jeffrey Michael Lipton;Naomi Taylor;Patrick G. Gallagher;Mohandas Narla;John D. Crispino;Lionel Blanc
  • 通讯作者:
    Lionel Blanc
Identification of Breakpoints of emRHD/em Hybrid Alleles By Long-Read Sequencing
通过长读长测序鉴定 emRHD/em 杂合等位基因的断点
  • DOI:
    10.1182/blood-2024-198223
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Ti-Cheng Chang;Jing Yu;Bensheng Ju;Melanie Loyd;Granger Ridout;Geoffrey A.M. Neale;Jane S Hankins;Mitchell J Weiss;Gorka Ochoa;Sunitha Vege;Stella T. Chou;John Easton;Yan Zheng
  • 通讯作者:
    Yan Zheng
Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease
  • DOI:
    10.1182/blood-2024-200330
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Alexis Kristine Leonard;Akshay Sharma;Yogindra Persaud;Parul Rai;Darla Pickett;Renee Massey;Neha Das Gupta;Subodh Selukar;Salem M. Akel;Leigh Poston;Yan Zheng;Ella Sorani;Irit Gliko Kabir;Mitchell J Weiss;Stephen Gottschalk;Julie Kanter;Matthew Hsieh;John Tisdale
  • 通讯作者:
    John Tisdale

Mitchell J Weiss的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mitchell J Weiss', 18)}}的其他基金

ULK-mediated autophagy of α-globin in ß-thalassemia
α-地中海贫血中 ULK 介导的 α-珠蛋白自噬
  • 批准号:
    10649565
  • 财政年份:
    2022
  • 资助金额:
    $ 20.03万
  • 项目类别:
ULK-mediated autophagy of α-globin in ß-thalassemia
α-地中海贫血中 ULK 介导的 α-珠蛋白自噬
  • 批准号:
    10539754
  • 财政年份:
    2022
  • 资助金额:
    $ 20.03万
  • 项目类别:
Core B: Human Stem Cell Core
核心B:人类干细胞核心
  • 批准号:
    8698736
  • 财政年份:
    2014
  • 资助金额:
    $ 20.03万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    9242002
  • 财政年份:
    2014
  • 资助金额:
    $ 20.03万
  • 项目类别:
Regulation of erythropoiesis by the miR-144/451 microRNA locus
miR-144/451 microRNA 位点对红细胞生成的调节
  • 批准号:
    8726379
  • 财政年份:
    2014
  • 资助金额:
    $ 20.03万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    9025774
  • 财政年份:
    2014
  • 资助金额:
    $ 20.03万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    8843634
  • 财政年份:
    2014
  • 资助金额:
    $ 20.03万
  • 项目类别:
Regulation of erythropoiesis by the miR-144/451 microRNA locus
miR-144/451 microRNA 位点对红细胞生成的调节
  • 批准号:
    8868445
  • 财政年份:
    2014
  • 资助金额:
    $ 20.03万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    8819535
  • 财政年份:
    2014
  • 资助金额:
    $ 20.03万
  • 项目类别:
Regulation of erythropoiesis by the miR-144/451 microRNA locus
miR-144/451 microRNA 位点对红细胞生成的调节
  • 批准号:
    8546340
  • 财政年份:
    2012
  • 资助金额:
    $ 20.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了